Pharmaceutical outsourcing provider, PCI Pharma Services, has acquired Dublin-based pharmaceutical and healthcare contract packaging services provider, Millmount Healthcare.
Dublin
“We are very excited to welcome the Millmount team to PCI,” commented Bill Mitchell, president and CEO. “We continue to see strong demand from our customers for medicines targeted for international growth markets both in commercial medicines as well as investigational medicines for clinical trials.”
This acquisition is the fourth PCI has made outside of the US and is demonstrative of the company’s commitment to continued growth and geographical expansion.
“With Millmount’s geographic presence in the European Union, we also see tremendous value in helping mitigate any uncertainty brought about by the evolving Brexit situation,” Mitchell added. “We see Millmount’s strengths and investments as complementary to PCI’s, and this will further help us deliver the industry leading experience to our clients as we partner in delivering life-saving medicines to patients around the world.”
Pascal Keogh, the founder of Millmount, said: “I am delighted Millmount is joining the PCI community and firmly believe this is a very positive event for our employees and customers. PCI is clearly a market-leading, global organisation that will allow Millmount to expand into new service lines, including serialisation, as well as accelerate growth of the business.”
This new acquisition increases PCI’s facilities to 18 in both North America and Europe. Furthermore, Millmount is licensed to support clinical trial medicines, and PCI expects to initiate site training and facility upgrades to support storage, distribution and QP release of clinical trial supplies immediately.